USPTO serial 76242426
REDEFINING PHARMACY TECHNOLOGY
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- PENDLETON, CAROLYN A
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with REDEFINING PHARMACY TECHNOLOGY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Clark R. Cowley
CLARK R COWLEY WHITAKER, CHALK, SWINDLE, & SAWYER, LLP3500 CITY CTR TWR II301 COMMERCE STFT WORTH, TX 76102-4140Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | computer software for patient data and providing counseling regarding disease management, prescription drugs and prescription compliance; for identifying patient prescriptions not in compliance and for notifying patients regarding the need for and availability of prescription refills; for processing and tracking health insurance claims and transferring health insurance claims to the appropriate insurance carriers for use in healthcare management and for use in disease management and prescription management | ACTIVE | — |
| 035 | providing accounting, inventory and administrative services via a global computer network for pharmacies, physicians and other healthcare providers, for the purpose of filling prescriptions for and providing disease management and healthcare services to their patients | ACTIVE | — |
| 042 | providing an on-line computer database in the field of health, specifically, providing a computer database of information respecting chemistry, pharmacological characteristics, indications, contra-indications and related information, concerning various drugs for use by pharmacies, and pharmacists for purposes of counseling patients regarding prescription compliance; providing health information to pharmacies regarding, and identifying for pharmacies, patient prescriptions that are not in compliance, and notifying and providing health information to patients regarding the need for and availability of prescription refills; assisting healthcare and pharmaceutical practitioners in providing counseling to patients regarding disease management and prescription drug information; creating a computer database for use by pharmacies and other health care providers that contains information concerning patients, drug disease states and third-party payor information while securely protecting patient confidentiality; and providing an on-line computer database featuring health care information while securely protecting patient confidentiality | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by National Health Network, Inc.
- Other trademarks owned by National Health Network, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named REDEFINING PHARMACY TECHNOLOGY
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 15, 2005 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 15, 2005 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 15, 2004 | CFIT | CASE FILE IN TICRS | — |
| Dec 11, 2003 | LEXT | LATE FILED EXTENSION REQUEST | — |
| Dec 11, 2003 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 20, 2003 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 23, 2003 | PAPER RECEIVED | — | |
| May 20, 2003 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 3, 2002 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 10, 2002 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 21, 2002 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 26, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 20, 2002 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jan 22, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 24, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 22, 2001 | DOCK | ASSIGNED TO EXAMINER | — |